Cannabinoids Clinical Trials Download Patients 
TheAnswerPage
JANUARY 11, 2022
Are you able to answer your patients’ medical marijuana questions? We also provide free downloadable resources: ‘The Endocannabinoid System and Medical Marijuana in 15 minutes!’ and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’
Greencamp
FEBRUARY 17, 2019
The stress response in IBS patients causes abnormalities in the functioning of the sympathetic nervous system (one of the divisions of the autonomic or “subconscious” nervous system) and to the HPA axis. We produce endocannabinoids—internal cannabinoid-like compounds, that bind to these cellular endocannabinoid receptors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
NOVEMBER 24, 2019
Do not offer CBD to manage chronic pain in adults unless as part of a clinical trial. After the 4-week trial, continue THC:CBD spray if the person has had at least a 20% reduction in spasticity-related symptoms on a 0 to 10 patient-reported numeric rating scale. the person’s clinical condition is stable.
CannaMD
MARCH 8, 2020
In January of 2020, the Journal of the American College of Cardiology published a review titled Marijuana Use in Patients With Cardiovascular Disease. Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk. population, has an arrhythmia.
CannaMD
MARCH 8, 2021
If you’re a Florida medical marijuana patient, chances are you’ve heard of House Bill 1455 – a proposed bill making its rounds through the state legislature as we speak. But, behind the outrage, lies a larger conversation regarding free speech, fair pricing, and the sanctity of the physician-patient relationship.
Project CBD
FEBRUARY 28, 2023
sativa do not naturally contain cannabinoids, but they can become contaminated with CBD from other plant parts during processing. 13 Although many review authors reported inconclusive findings due to low-quality studies, they noted that evidence from human clinical trials seems to support CBD’s positive effects on nociceptive pain (i.e.,
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.
Expert insights. Personalized for you.
98 
Let's personalize your content